ARBORXR
7.10.2021 16:55:09 CEST | Business Wire | Press release
ArborXR , the leading enterprise AR/VR device management and content distribution platform, and AR/VR solutions distributor, Matts Digital , today announced a partnership to provide frictionless extended reality (XR) solutions at scale in Europe and beyond. With ArborXR’s mobile device management (MDM) software, Matts Digital will help companies securely manage fleets of XR devices, deploy apps and files remotely, and control the in-headset user experience. The partnership illustrates an accelerated shift to remote work and training amid the pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211007005755/en/
According to Forbes , global spending on AR/VR rose to $12 billion in 2020, up 50 percent from 2019.
“ArborXR and Matts Digital share a mission to help companies use and scale XR technology with ease, while offering exceptional customer service,” said ArborXR Co-Founder Will Stackable. “By partnering with Matts Digital, ArborXR is able to help global enterprise companies succeed and increase efficiency through the power of XR. We’re thrilled to enter the European market and provide vital software to help companies deploy AR/VR with confidence.”
Matts Digital offers an extensive range of AR/VR products, in addition to unique XR technology professional services. By utilizing ArborXR’s software, Matts Digital will help companies manage thousands of devices with security and control.
“Matts Digital is pleased to work with ArborXR to offer best-in-class XR solutions for a variety of global companies. Together, we will help customers use XR devices with confidence and achieve our shared goal to increase the simplicity, security and efficiency of XR in the workplace,” Matts Digital President Stephane Courgeon said.
To learn more about ArborXR or Matts Digital, visit ArborXR.com or Matts-Digital.com .
About ArborXR
ArborXR is AR/VR mobile device management (MDM) software that allows enterprise companies to securely manage fleets of XR devices, deploy apps and files remotely, and control the in-headset experience. It is used by Fortune 500 companies, businesses, and hundreds of independent software vendors to seamlessly manage devices, enroll and provision headsets, deploy apps and files remotely, and lock down the user experience with kiosk mode and a multi-app launcher. Learn more about ArborXR and its recent completion of a Series A at ArborXR.com .
About Matts Digital
Matts Digital is a Value-Added distributor, specializing in Virtual Reality (VR) and Augmented Reality (AR) solutions. We offer a full range of headsets, peripherals, accessories and hygiene products, as well as unique professional services in this area. Our significant industrial and logistical capacity allows our customers to easily consider the deployment of their ARVR projects on a large scale, in France and abroad. Learn more at Matts-Digital.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211007005755/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom